Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 57, Issue 11, 1998, Pages 1041-1052

  Masliah, Eliezer ^a,b,c   Mallory, Margaret ^a,c   Alford, Michael ^a,c   Tanaka, Seigo ^c   Hansen, Lawrence A ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Amyloid precursor protein; Excitotoxicity; Glutamate transporter; Neurodegeneration

Indexed keywords

DNA FRAGMENT;

ALZHEIMER DISEASE; ARTICLE; CELL DEATH; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NERVE DEGENERATION; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0031760611     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199811000-00007     Document Type: Article

References (85)

1. Wilcock GK, Esiri MM, Bowen DM, Hughes AO. The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type. J Neurol Neurosurg Psych 1988;51:842-49
2. Perry EK, Perry RH, Blessed G, Tomlinson BE. Neurotransmitter enzyme abnormalities in senile dementia: CAT and GAD activities in necropsy tissue. J Neurol Sci 1977;34:247-65
3. Palmer AM, Gershon S. Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? FASEB J 1990;2745:52
4. Masliah E, Mallory M, Hansen L, Alford M, DeTeresa R, Terry R. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am J Pathol 1993;142:871-82
5. Hyman BT, VanHoesen GW, Damasio AR, Barnes CL. Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation. Science 1984;225:1168-70
6. Hof PR, Cox K, Morrison JH. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex. J Comp Neurol 1990;301:44-54
7. Terry RD, Hansen L, Masliah E. Structural alterations in Alzheimer disease. In: Terry RD, Katzman R, eds. Alzheimer disease. New York: Raven Press, 1994:179-96
8. Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 1989;2:420-36
9. Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988;9:339-49
10. Masliah E, Mallory M, Hansen L, et al. Immunoreactivity of CD45, a protein phosphotyrosine phosphatase, in Alzheimer disease. Acta Neuropathol 1991;83:12-20
11. Sisodia SS, Price DL. Role of the beta-amyloid protein in Alzheimer's disease. FASEB J 1995;9:366-70
12. Masliah E. Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer's disease. Lab Invest 1997;77: 197-209
13. Price DL, Sisodia SS, Gandy SE. Amyloid beta amyloidosis in Alzheimer's disease. Curr Opin Neurol 1995;8:268-74
14. Selkoe D. Cell biology of the amyloid β-protein precursor and the mechanisms of Alzheimer's disease. Annu Rev Cell Biol 1994;10: 373-403
15. 2+ homeostasis in Alzheimer's disease. TINS 1993;16:409-14
16. Li S, Mallory M, Alford M, Tanaka S, Masliah E. Glutamate transporter alterations in Alzheimer's disease. J Neuropathol Exp Neurol 1997;56:901-11
17. Pike CJ, Ramezan-Arab N, Miller S, Cotman CW. beta amyloid increases enzyme activity and protein levels of glutamine synthetase in cultured astrocytes. Exp Neurol 1996;139:167-71
18. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992;12:376-89
19. Bancher C, Lassmann H, Breitschopf H, Jellinger KA. Mechanisms of cell death in Alzheimer's disease. J Neural Transm 1997;50:141-52
20. Busciglio J, Yankner BA. Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 1995;378:776-79
21. Gschwind M, Huber G. Apoptotic cell death induced by β-amyloid 1-42 peptide is cell type dependent. J Neurochem 1995;65:292-300
22. Li Y-P, Bushnell AF, Lee C-M, Perlmutter LS, Wong SK-F. β-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 1996;738:196-204
23. Smale G, Nichols NR, Brady DR, Finch CE, Horton WE Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp Neurol 1995;133:225-30
24. Li WP, Chan WY, Lai HWL, Yew DT. Terminal dUTP nick end labeling (TUNEL) positive cells in the different regions of the brain in normal aging and Alzheimer patients. J Mol Neurosci 1997;8: 75-82
25. Lassmann H, Bancher C, Breitschopf H, et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995;89:35-41
26. Su JH, Anderson AJ, Cummings BJ, Cotman CW. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 1994;5:2529-33
27. Parpura-Gill A, Beitz D, Uemura E. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res 1997;754:65-71
28. Mullaart E, Boerrigter ME, Ravid R, Swaab DF, Vijg J. Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging 1990;11:169-73
29. Anderson AJ, Su JH, Cotman CW. DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area and effect of postmortem delay. J Neurosci 1996;16:1710-19
30. Vekrellis K, McCarthy MJ, Watson A, Whitfield J, Rubin LL, Ham J. Bax promotes neuronal cell death and is downregulated during the development of the nervous system. Development 1997;124: 1239-49
31. Su JH, Deng G, Cotman CW. Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression and brain pathology. J Neuropathol Exp Neurol 1997;56: 86-93
32. Satou T, Cummings BJ, Cotman CW. Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 1995;697:35-43
33. Vyas S, Javoy-Agid F, Herrero M-T, et al. Expression of Bcl-2 in adult human brain regions with special reference to neurodegenerative disorders. J Neurochem 1997;69:223-31
34. Paradis E, Douillard H, Koutroumanis M, Goodyear C, LeBlanc A. Amyloid b peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J Neurosci 1996;16: 7533-39
35. Drache B, Diehl GE, Beyreuther K, Perlmutter LS, Konig G. Bcl-x1-specific antibody labels activated microglial associated with Alzheimer's disease and other pathological states. J Neurosci Res 1997;47:98-108
36. Kitamura Y, Shimohama S, Kamoshima W, Matsuoka Y, Nomura Y, Taniguchi T. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem Biophys Res Commun 1997;232:418-21
37. Nishimura T, Akiyama H, Yonehara S, et al. Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 1995;695:137-45
38. Talanian RV, Quinlan C, Trautz S, et al. Substrate specificities of caspase family proteases. J Biol Chem 1997;272:9677-82
39. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996;10:587-97
40. Chinnaiyan AM, Orth K, O'Rourke K, Duan H, Poirier GG, Dixit VM. Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem 1996;271:4573-76
41. Alnemri ES, Livingston DJ, Nicholson DW, et al. Human ICE/ CED-3 protease nomenclature. Cell 1996;87:171
42. Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptosis protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 1995;377:446-48
43. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to C. Elegans cell death protein Ced-3 and mammalian iterleukin-1 beta converting enzyme. J Biol Chem 1994;269:30761-64
44. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Eamshaw WC. Cleavage of poly(ADP-rihose) polymerase by a proteinase with properties like ICE. Nature 1994;371:346-47
45. Terry RD, Katzman R. Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-508
46. Hansen LA, Masliah E, Qijada-Fawcett S, Rexin D. Entorhinal neurofibrillary tangles in Alzheimer's disease with Lewy bodies. Neurosci Lett 1991;129:269-72
47. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501
48. Masliah E, Terry RD, Alford M, DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: An alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 1990;38:837-44
49. Masliah E, Alford M, DeTeresa R, Mallory M, Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 1996;40:759-66
50. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993;90:6591-95
51. Portera-Cailliau C, Price DL, Martin LJ. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologicallly distinct: Further evidence for an apoptosis-necrosis continuum. J Comp Neurol 1997;378:88-104
52. Rockenstein EM, McConlogue L, Tan H, Power M, Masliah E, Mucke L. Levels and alternative splicing of amyloid b protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J Biol Chem 1995;270:28257-67
53. Scott HL, Tannenberg AEG, Dodd PR. Variant forms of neuronal glutamate trasporter sites in Alzheimer's disease cerebral cortex. J Neurochem 1995;64:2193-202
54. Cowburn R, Hardy J, Roberts P, Briggs R. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci Lett 1988;86:109-13
55. Cowburn RF, Hardy JA, Roberts PJ. Glutamatergic neurotransmission in Alzheimer's disease. Biochem Soc Trans 1990;18:390-92
56. Masliah E, Iimoto D, Saitoh T, Hansen LA, Terry RD. Increased immunoreactivity of brain spectrin in Alzheimer disease: A marker for synapse loss? Brain Res 1990;531:36-44
57. Butterfield DA, Hensley K, Cole P, et al. Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: Relevance to Alzheimer's disease. J Neurochem 1997;68:2451-57
58. Gunnersen D, Haley B. Detection of glutamine synthetase in the cerebrospinal fluid of Alzheimer diseased patients: A potential diagnostic biochemical marker. Proc Natl Acad Sci USA 1992;89: 11949-53
59. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 1993;10:243-54
60. Mucke L, Abraham CR, Ruppe MD, et al. Protection against HIV-1 gp120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP). J Exp Med 1995;181:1551-56
61. Masliah E, Westland CE, Abraham CR, et al. Amyloid precursor protein protects neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo. Neurosci 1997;78:135-41
62. Masliah E, Raber J, Alford M, et al. Regulation of excitatory amino acid transporters by amyloid protein precursor (APP) and its relations to neuroprotective APP effects in transgenic mice. J Biol Chem 1998;273:12548-54
63. Harris ME, Carney JM, Cole PS, et al. beta-amyloid peptide-derived, oxygen-dependent free radicals inhibit gluatamate uptake in cultured astrocytes; implications for Alzheimer's disease. Neuro-Report 1995;6:1875-79
64. Blanc EM, Toborek M, Mark RJ, Hennig B, Mattson MP. Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 1997;68:1870-81
65. Thorns V, Mallory M, Hansen L, Masliah E. Alterations in glutamate receptor 2/3 subunits and amyloid precursor protein expression during the course of Alzheimer's disease and Lewy body variant. Acta Neuropathol 1997;94:539-46
66. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-86
67. Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate trasporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84
68. MacManus JP, Rasquinha I, Black MA, et al. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine. Exp Cell Res 1997;233:310-20
69. Larm JA, Cheung NS, Beart PM. Apoptosis induced via AMPA-selective receptors in cultured murine cortical neurons. J Neurochem 1997;69:617-22
70. Perez MT, Amer K, Hakansson A. DNA fragmentation characteristic of apoptosis and cell loss induced by kainic acid in rabbit retinas. Neurochem Int 1997;31:251-60
71. Didier M, Bursztajn S, Adamec E, et al. DNA strand breaks induced by sustained glutamat excitotoxicity in primary neuronal cultures. J Neurosci 1996;16:2238-50
72. Gold R, Schmied M, Rothe G, et al. Detection of DNA fragmentation in apoptosis: application of in situ nick translation to cell culture ssystems and tissue sections. J Histochem Cytochem 1993;41:1023-30
73. Wijsman JH, Jonker RR, Keijzer R, Van de Velde CJH, Cornelisse CJ, van Dierendonck JH. A new method to detect apoptosis in parafiin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12
74. Charriaut-Marlangue C, Ben-Ari Y. A cautionary note on the use of the TUNEL stain to determine apoptosis. NeuroReport 1995;7: 61-64
75. Stadelmann C, Bruck W, Bancher C, et al. Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 1998;57:456-64
76. Martin SJ, Green DR. Protease activation during apoptosis: Death by a thousand cuts? Cell 1995;82:349-52
77. Yuan J, Shaham S, Ledoux S, Ellis HM, Horovitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-convertin enzyme. Cell 1993;75:641-52
78. Miura M, Zhu H, Robello R, Hartweig EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. J Cell 1994;75: 553-60
79. Krajewska M, Wang H-G, Krajewski S, et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 1997;57:1605-13
80. Keane RW, Srinivasan A, Foster LM, et al. Activation of CPP32 during apoptosis of neurons and astrocytes. J Neurosci Res 1997;48: 168-80
81. Kim T, Pettingell WH, Jung Y, Kovacs DM, Tanzi RE. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a Caspase-3 family protease. Science 1997;277:373
82. Guo Q, Sopher BL, Furukawa K, et al. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals. J Neurosci 1997;17:4212-22
83. Wolozin B, Iwasaki K, Vito P, et al. Participation of Presenilin 2 in apoptosis: Enhanced basal activity conferred by an Alzheimer mutation. Science 1996;274:1710-13
84. LaFerla FM, Hall CK, Ngo L, Jay G. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J Clin Invest 1996;98:1626-32
85. Zhao B, Chrest FJ, Horton WE Jr, Sisodia SS, Kusiak JW. Expression of mutant amyloid precursor proteins induces apoptosis in PC12 cells. J Neurosci Res 1997;47:253-63